Skip Content
You are currently on the new version of our website. Access the old version .

Future Pharmacology, Volume 4, Issue 3

2024 September - 11 articles

Cover Story: Psychopharmacology is moving toward personalized medicine, recognizing significant sex-based differences in drug responses. These disparities result from biological, psychological, and social factors. Pharmacokinetic differences arise from variations in drug absorption, distribution, metabolism, and excretion influenced by hormones and body composition. Pharmacodynamic differences result from variations in receptor expression and sensitivity. To optimize treatment outcomes, it is crucial to consider sex-based differences in drug responses. Future research should focus on large-scale studies, personalized medicine, and drug development to address sex-specific needs. By understanding these differences, clinicians can tailor treatments to individual patients, improving outcomes, reducing adverse events, and minimizing risks. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Review
  • Open Access
7 Citations
3,531 Views
25 Pages

Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment

  • Yeva Meshkovska,
  • Artem Abramov,
  • Shaheen Mahira and
  • Sowjanya Thatikonda

Ovarian cancer (OC) ranks as the fifth most common cancer among women in the United States and globally, posing a significant health threat. Reactive oxygen species (ROS) have emerged as critical factors in the pathophysiology of this malignancy. ROS...

  • Systematic Review
  • Open Access
2 Citations
2,491 Views
25 Pages

Esophageal cancer (EC) is a very common form of cancer in developing countries, and its exponential progression is a cause for concern. Available treatments face the phenomenon of multi-drug resistance, as well as multiple disabling side effects. The...

  • Systematic Review
  • Open Access
7 Citations
6,531 Views
36 Pages

Cannabis sativa L. has garnered attention as a potential source for new antimicrobial agents, particularly due to the increased prevalence of microbial resistance to conventional antimicrobials and the emergence of multidrug-resistant pathogens. This...

  • Review
  • Open Access
1 Citations
4,162 Views
16 Pages

Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility

  • David R. Skvarc,
  • Trang T. T. Truong,
  • Robert M. Lundin,
  • Russell Barnes,
  • Fiona A. Wilkes and
  • Ajeet B. Singh

Genetic factors influence medication response (pharmacogenetics), affecting the pharmacodynamics and pharmacokinetics of many medicaments used in clinical care. The ability of medications to cross the blood–brain barrier (BBB) represents a crit...

  • Article
  • Open Access
4 Citations
2,990 Views
10 Pages

Anticancer Activity of 4-Aryl-1,4-Dihydropyridines

  • Thaís A. S. Oliveira,
  • Jackson B. A. Silva,
  • Tábata R. Esperandim,
  • Nathália O. Acésio,
  • Denise C. Tavares and
  • Antônio E. M. Crotti

We have synthesized 22 symmetric and asymmetric 4-aryl-1,4-dihydropyridines (1,4-DHPs) by a “green” microwave-assisted one-pot multicomponent Hantzsch reaction and evaluated their cytotoxicity to three human cancer cell lines regarding U-...

  • Review
  • Open Access
2 Citations
2,984 Views
23 Pages

Beyond One-Size-Fits-All: Personalized Medicine and Future Directions in Sex-Based Psychopharmacological Treatment

  • Marianna Mazza,
  • Francesco Maria Lisci,
  • Caterina Brisi,
  • Gianandrea Traversi,
  • Eleonora Gaetani,
  • Roberto Pola and
  • Giuseppe Marano

Sex-related differences in psychopharmacology present unique challenges in both clinical and research settings. Recognition of sex differences in psychopharmacological treatment has increased in recent years, but a significant research gap regarding...

  • Review
  • Open Access
2 Citations
3,584 Views
31 Pages

(1) Background: The SARS-CoV-2 papain-like protease (PLpro) remains an underexplored antiviral target so far. The reduced efficacy of approved treatments against novel variants highlights the importance of developing new agents. This review aims to p...

  • Article
  • Open Access
7 Citations
6,716 Views
16 Pages

Preclinical Pharmacology of the Low-Impact Ampakine CX717

  • Daniel P. Radin,
  • Sheng Zhong,
  • Rok Cerne,
  • Jodi L. Smith,
  • Jeffrey M. Witkin and
  • Arnold Lippa

Ampakines are a class of orally available positive allosteric modulators of the AMPA-glutamate receptor (AMPAR) and have therapeutic implications for neurological/neuropsychiatric disorders in which AMPAR signaling is compromised. Low-impact ampakine...

  • Review
  • Open Access
1 Citations
3,928 Views
15 Pages

The membrane impermeability of a drug poses a significant challenge in drug research and development, preventing effective drug delivery to the target site. Specifically, the blood-brain barrier (BBB) presents a formidable obstacle to the delivery of...

  • Review
  • Open Access
2 Citations
1,854 Views
13 Pages

Breast cancer is the most common type of cancer globally and presents an escalating problem and a huge burden on societies. Several strategies are implemented in clinics to treat patients and prevent disease incidence. Efforts to understand the under...

  • Article
  • Open Access
3 Citations
3,173 Views
17 Pages

Eugenol-Rich Essential Oils from Flower Buds and Leaves of Syzygium aromaticum Show Antifungal Activity against Candida and Cryptococcus Species

  • Evariste Josué Momo,
  • François Nguimatsia,
  • Laure Ateufouet Ngouango,
  • Paul Keilah Lunga,
  • Boniface Pone Kamdem and
  • Pierre Michel Jazet Dongmo

Plants from the Myrtaceae family are known to contain considerable quantities of volatile compounds, ranging from oxygenated monoterpenes to hydrogenated sesquiterpenes, and others, which exhibit antimicrobial activity. One such plant includes Syzygi...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Future Pharmacol. - ISSN 2673-9879